2023
DOI: 10.1152/ajpcell.00377.2022
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondrial creatine sensitivity is lost in the D2.mdx model of Duchenne muscular dystrophy and rescued by the mitochondrial-enhancing compound Olesoxime

Abstract: Duchenne muscular dystrophy (DMD) is associated with distinct mitochondrial stress responses. Here, we aimed to determine whether the prospective mitochondrial-enhancing compound Olesoxime prevents early-stage mitochondrial stress in limb and respiratory muscle from D2.mdx mice using a proof-of-concept short-term regimen spanning 10-28 days of age. As mitochondrial-cytoplasmic energy transfer occurs via ATP- or phosphocreatine-dependent phosphate shuttling, we assessed bioenergetics with or without creatine in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
17
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
3

Relationship

4
3

Authors

Journals

citations
Cited by 15 publications
(29 citation statements)
references
References 72 publications
3
17
1
Order By: Relevance
“…We were unable to assess cardiac function in aged D2.mdx mice due to their qualitatively frail nature. Furthermore, while we did not see robust differences in grip strength compared to agematched wild type mice, we did note that the absolute values of grip strength in the 12 month old wild type mice are ~50% of the values we have reported previously in this strain at 4 weeks of age [7,16] suggesting an aging effect occurred in the control group. Nonetheless, the other parameters demonstrate a severe myopathy in the aged D2.mdx mice.…”
Section: Discussioncontrasting
confidence: 86%
See 2 more Smart Citations
“…We were unable to assess cardiac function in aged D2.mdx mice due to their qualitatively frail nature. Furthermore, while we did not see robust differences in grip strength compared to agematched wild type mice, we did note that the absolute values of grip strength in the 12 month old wild type mice are ~50% of the values we have reported previously in this strain at 4 weeks of age [7,16] suggesting an aging effect occurred in the control group. Nonetheless, the other parameters demonstrate a severe myopathy in the aged D2.mdx mice.…”
Section: Discussioncontrasting
confidence: 86%
“…The greater abundance of cysteine oxidation on mtCK was consistent with higher rates of creatine-sensitive mH2O2 during oxidative phosphorylation and the more oxidized cellular environment (lower GSH:GSSG). mtCK oxidation may be unique to advanced stages of this disease, given we previously reported no differences in 4-week D2.mdx mice, at least in skeletal muscle [16]. Further studies could examine the precise form of thiol modification that occurs in aged D2.mdx mice, such as glutathionylation, considering its emerging role in linking redox signaling to metabolic control [20,21] and considering the shift in GSH:GSSG noted in the present study.…”
Section: Discussionmentioning
confidence: 64%
See 1 more Smart Citation
“…25M, 100M and 500M ADP were selected to reflect creatine sensitivity as this is within the predicted range that is sensitive to the effects of mitochondrial creatine kinase (mtCK) [23,[46][47][48]. Maximal ADP-stimulated respiration was Another approach for evaluating changes in the relative control exerted by mitochondrial creatine kinase on ADP-stimulated respiration, or 'mitochondrial creatine sensitivity', is to calculate the ratio of respiration at submaximal ADP concentrations in both +Creatine/-Creatine conditions [16,23,28,46,49]. In the TA, creatine sensitivities were unchanged across time points indicating alterations in respiration were similar between both high energy phosphate shuttling systems (SFigure 4E).…”
Section: Decreases In Carbohydrate Supported Mitochondrial Respiratio...mentioning
confidence: 99%
“…Given that adiponectindeficient mice have impaired recognition memory (Bloemer et al, 2019), we hypothesized that a recently developed slow-release formulation (ALY688-SR) with improved pharmacokinetic properties enabling once-daily injection (Allysta Pharmaceutical, unpublished observations) would improve memory during early disease stages in young D2.mdx mice, in association with lower inflammation and enhanced mitochondrial metabolism. (Bellissimo et al, 2023;Coley et al, 2016;Hughes et al, 2020Hughes et al, , 2019Ramos et al, 2020). Mice were killed 20-24 h after the last dose.…”
Section: Introductionmentioning
confidence: 99%